Racial differences in genome-wide methylation profiling and gene expression in breast tissues from healthy women

Epigenetics

Volumn 10, Issue 12, 2015, Pages 1177-1187

  Song, Min Ae ^a   Brasky, Theodore M ^a   Marian, Catalin ^a,b   Weng, Daniel Y ^a   Taslim, Cenny ^a   Dumitrescu, Ramona G ^c   Llanos, Adana A ^d   Freudenheim, Jo L ^e   Shields, Peter G ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c Distilled Spirits Council of the United States   (United States)

^d RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

Author keywords

breast; disparity; gene expression; genome wide DNA methylation; race

Indexed keywords

METHYL CPG BINDING PROTEIN; UBIQUITIN C; TRANSCRIPTOME; TUMOR MARKER;

ADULT; AFRICAN AMERICAN; ANALYTIC METHOD; ARTICLE; BREAST CANCER; CELL DEATH; CELL SURVIVAL; DNA METHYLATION; EUROPEAN AMERICAN; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; LOCUS BY LOCUS ANALYSIS; NORMAL HUMAN; PYROSEQUENCING; RACE DIFFERENCE; TRANSCRIPTION INITIATION SITE; BREAST; BREAST TUMOR; CAUCASIAN; CPG ISLAND; ETHNOLOGY; GENETIC EPIGENESIS; GENETICS; GENOME-WIDE ASSOCIATION STUDY; METABOLISM; MIDDLE AGED; PROMOTER REGION; RISK FACTOR; STATISTICAL MODEL;

ADULT; AFRICAN AMERICANS; BIOMARKERS, TUMOR; BREAST; BREAST NEOPLASMS; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LINEAR MODELS; MIDDLE AGED; PROMOTER REGIONS, GENETIC; RISK FACTORS; TRANSCRIPTOME;

EID: 84961642717     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.1080/15592294.2015.1121362     Document Type: Article

References (44)

1. R.L.Siegel, K.D.Miller, A.Jemal. Cancer statistics, 2015. CA 2015; 65:5-29; PMID:25559415
2. C.B.Ambrosone, A.C.Young, L.E.Sucheston, D.Wang, L.Yan, S.Liu, L.Tang, Q.Hu, J.L.Freudenheim, P.G.Shields, et al. Genome-wide methylation patterns provide insight into differences in breast tumor biology between American women of African and European ancestry. Oncotarget 2014; 5:237-48; PMID:24368439; http://dx.doi.org/10.18632/oncotarget.1599
3. S.Wang, T.H.Dorsey, A.Terunuma, R.A.Kittles, S.Ambs, B.Kwabi-Addo. Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer. PloS One 2012; 7:e37928; PMID:22701537; http://dx.doi.org/10.1371/journal.pone.0037928
4. P.M.Das, R.Singal. DNA methylation and cancer. J Clin Oncol 2004; 22:4632-42; PMID:15542813; http://dx.doi.org/10.1200/JCO.2004.07.151
5. B.C.Christensen, K.T.Kelsey, S.Zheng, E.A.Houseman, C.J.Marsit, M.R.Wrensch, J.L.Wiemels, H.H.Nelson, M.R.Karagas, L.H.Kushi, et al. Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake. PLoS Genet 2010; 6:e1001043; PMID:20686660; http://dx.doi.org/10.1371/journal.pgen.1001043
6. K.C.Johnson, D.C.Koestler, C.Cheng, B.C.Christensen. Age-related DNA methylation in normal breast tissue and its relationship with invasive breast tumor methylation. Epigenetics 2014; 9:268-75; http://dx.doi.org/10.4161/epi.27015
7. M.H.Tao, C.Marian, P.G.Shields, J.Nie, S.E.McCann, A.Millen, C.Ambrosone, A.Hutson, S.B.Edge, S.S.Krishnan, et al. Alcohol consumption in relation to aberrant DNA methylation in breast tumors. Alcohol 2011; 45:689-99; PMID:21168302; http://dx.doi.org/10.1016/j.alcohol.2010.11.006
8. M.H.Tao, C.Marian, J.Nie, C.Ambrosone, S.S.Krishnan, S.B.Edge, M.Trevisan, P.G.Shields, J.L.Freudenheim. Body mass and DNA promoter methylation in breast tumors in the Western New York Exposures and Breast Cancer Study. Am J Clin Nutri 2011; 94:831-8; PMID:21775555; http://dx.doi.org/10.3945/ajcn.110.009365
9. K.Conway, S.N.Edmiston, C.K.Tse, C.Bryant, P.F.Kuan, B.Y.Hair, E.A.Parrish, R.May, T.Swift-Scanlan. Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study. Cancer Epidemiology Biomarkers Prevention 2015; 24:921-30; http://dx.doi.org/10.1158/1055-9965.EPI-14-1228
10. R.G.Dumitrescu, C.Marian, S.S.Krishnan, S.L.Spear, B.V.Kallakury, D.J.Perry, J.R.Convit, F.Seillier-Moiseiwitsch, Y.Yang, J.L.Freudenheim, et al. Familial and racial determinants of tumour suppressor genes promoter hypermethylation in breast tissues from healthy women. J Cell Mol Med 2010; 14:1468-75; PMID:19799643; http://dx.doi.org/10.1111/j.1582-4934.2009.00924.x
11. A.A.Llanos, R.G.Dumitrescu, T.M.Brasky, Z.Liu, J.B.Mason, C.Marian, K.H.Makambi, S.L.Spear, B.V.Kallakury, J.L.Freudenheim, et al. Relationships among folate, alcohol consumption, gene variants in one-carbon metabolism and p16INK4a methylation and expression in healthy breast tissues. Carcinogenesis 2015; 36:60-7; PMID:25344837; http://dx.doi.org/10.1093/carcin/bgu219
12. A.A.Llanos, C.Marian, T.M.Brasky, R.G.Dumitrescu, Z.Liu, J.B.Mason, K.H.Makambi, S.L.Spear, B.V.Kallakury, J.L.Freudenheim, et al. Associations between genetic variation in one-carbon metabolism and LINE-1 DNA methylation in histologically normal breast tissues. Epigenetics 2015; 10:727-35; http://dx.doi.org/10.1080/15592294.2015.1062205
13. F.F.Zhang, R.Cardarelli, J.Carroll, K.G.Fulda, M.Kaur, K.Gonzalez, J.K.Vishwanatha, R.M.Santella, A.Morabia. Significant differences in global genomic DNA methylation by gender and race/ethnicity in peripheral blood. Epigenetics 2011; 6:623-9; http://dx.doi.org/10.4161/epi.6.5.15335
14. M.B.Terry, J.S.Ferris, R.Pilsner, J.D.Flom, P.Tehranifar, R.M.Santella, M.V.Gamble, E.Susser. Genomic DNA methylation among women in a multiethnic New York City birth cohort. Cancer Epidemiology Biomarkers Prevention 2008; 17:2306-10; http://dx.doi.org/10.1158/1055-9965.EPI-08-0312
15. R.M.Adkins, J.Krushkal, F.A.Tylavsky, F.Thomas. Racial differences in gene-specific DNA methylation levels are present at birth. Birth Defects Res Clin Mol Teratology 2011; 91:728-36; PMID:21308978; http://dx.doi.org/10.1002/bdra.20770
16. C.Sotiriou, L.Pusztai. Gene-expression signatures in breast cancer. N Engl J Med 2009; 360:790-800; PMID:19228622; http://dx.doi.org/10.1056/NEJMra0801289
17. J.R.Pirone, M.D'Arcy, D.A.Stewart, W.C.Hines, M.Johnson, M.N.Gould, P.Yaswen, D.J.Jerry, Smith S.Schneider, M.A.Troester. Age-associated gene expression in normal breast tissue mirrors qualitative age-at-incidence patterns for breast cancer. Cancer Epidemiology Biomarkers Prevention 2012; 21:1735-44; http://dx.doi.org/10.1158/1055-9965.EPI-12-0451
18. X.Sun, P.Casbas-Hernandez, C.Bigelow, L.Makowski, D.Joseph Jerry, S.Smith Schneider, M.A.Troester. Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression. Breast Cancer Res Treatment 2012; 131:1003-12; PMID:22002519; http://dx.doi.org/10.1007/s10549-011-1789-3
19. M.Rotunno, X.Sun, J.Figueroa, M.E.Sherman, M.Garcia-Closas, P.Meltzer, T.Williams, S.S.Schneider, D.J.Jerry, X.R.Yang, et al. Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status. Breast cancer Res 2014; 16:R74; PMID:25005139; http://dx.doi.org/10.1186/bcr3689
20. X.Sun, G.L.Gierach, R.Sandhu, T.Williams, B.R.Midkiff, J.Lissowska, E.Wesolowska, N.F.Boyd, N.B.Johnson, J.D.Figueroa, et al. Relationship of mammographic density and gene expression: analysis of normal breast tissue surrounding breast cancer. Clin Cancer Res 2013; 19:4972-82; PMID:23918601; http://dx.doi.org/10.1158/1078-0432.CCR-13-0029
21. A.A.Llanos, T.M.Brasky, R.G.Dumitrescu, C.Marian, K.H.Makambi, B.V.Kallakury, S.L.Spear, D.J.Perry, R.J.Convit, M.E.Platek, et al. Plasma IGF-1 and IGFBP-3 may be imprecise surrogates for breast concentrations: an analysis of healthy women. Breast Cancer Res Treatment 2013; 138:571-9; PMID:23456194; http://dx.doi.org/10.1007/s10549-013-2452-y
22. J.Maksimovic, L.Gordon, A.Oshlack. SWAN: Subset-quantile within array normalization for illumina infinium HumanMethylation450 BeadChips. Genome Biol 2012; 13:R44; PMID:22703947; http://dx.doi.org/10.1186/gb-2012-13-6-r44
23. M.E.Price, A.M.Cotton, L.L.Lam, P.Farre, E.Emberly, C.J.Brown, W.P.Robinson, M.S.Kobor. Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array. Epigenetics Chromatin 2013; 6:4; PMID:23452981; http://dx.doi.org/10.1186/1756-8935-6-4
24. Y.A.Chen, M.Lemire, S.Choufani, D.T.Butcher, D.Grafodatskaya, B.W.Zanke, S.Gallinger, T.J.Hudson, R.Weksberg. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 2013; 8:203-9; http://dx.doi.org/10.4161/epi.23470
25. P.Du, X.Zhang, C.C.Huang, N.Jafari, W.A.Kibbe, L.Hou, S.M.Lin. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics 2010; 11:587; PMID:21118553; http://dx.doi.org/10.1186/1471-2105-11-587
26. J.Quackenbush. Computational analysis of microarray data. Nat Rev Genetics 2001; 2:418-27; PMID:11389458; http://dx.doi.org/10.1038/35076576
27. H.WilliamsHAaLJ. Principal component analysis. Wiley Interdisciplinary Rev 2010; 2:433-59; http://dx.doi.org/10.1002/wics.101
28. M.Bibikova, B.Barnes, C.Tsan, V.Ho, B.Klotzle, J.M.Le, D.Delano, L.Zhang, G.P.Schroth, K.L.Gunderson, et al. High density DNA methylation array with single CpG site resolution. Genomics 2011; 98:288-95; PMID:21839163; http://dx.doi.org/10.1016/j.ygeno.2011.07.007
29. C.Bock, J.Walter, M.Paulsen, T.Lengauer. CpG island mapping by epigenome prediction. PLoS Computational Biol 2007; 3:e110; PMID:17559301; http://dx.doi.org/10.1371/journal.pcbi.0030110
30. M.C.Lorincz, D.R.Dickerson, M.Schmitt, M.Groudine. Intragenic DNA methylation alters chromatin structure and elongation efficiency in mammalian cells. Nat Struct Mol Biol 2004; 11:1068-75; PMID:15467727; http://dx.doi.org/10.1038/nsmb840
31. A.R.Kornblihtt. Chromatin, transcript elongation and alternative splicing. Nat Struct Mol Biol 2006; 13:5-7; PMID:16395314; http://dx.doi.org/10.1038/nsmb0106-5
32. M.M.Suzuki, A.Bird. DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genetics 2008; 9:465-76; PMID:18463664; http://dx.doi.org/10.1038/nrg2341
33. P.A.Jones. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genetics 2012; 13:484-92; PMID:22641018; http://dx.doi.org/10.1038/nrg3230
34. J.R.Wagner, S.Busche, B.Ge, T.Kwan, T.Pastinen, M.Blanchette. The relationship between DNA methylation, genetic and expression inter-individual variation in untransformed human fibroblasts. Genome Biol 2014; 15:R37; PMID:24555846; http://dx.doi.org/10.1186/gb-2014-15-2-r37
35. T.Fleischer, A.Frigessi, K.C.Johnson, H.Edvardsen, N.Touleimat, J.Klajic, M.L.Riis, V.D.Haakensen, F.Warnberg, B.Naume, et al. Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis. Genome Biol 2014; 15:435; PMID:25146004
36. M.B.Lucia Radici, R.CrinelliRita, M.MagnaniMauro Ubiquitin C gene: Structure, function, and transcriptional regulation Adv Biosci Biotechnol 2013; 4:1057-62; http://dx.doi.org/10.4236/abb.2013.412141
37. T.Ohta, M.Fukuda. Ubiquitin and breast cancer. Oncogene 2004; 23:2079-88; PMID:15021895; http://dx.doi.org/10.1038/sj.onc.1207371
38. Y.Xiang, J.Zhang, K.Huang. Mining the tissue-tissue gene co-expression network for tumor microenvironment study and biomarker prediction. BMC Genomics 2013; 14 Suppl 5:S4; PMID:24564578; http://dx.doi.org/10.1186/1471-2164-14-S5-S4
39. J.Howlin, J.Rosenkvist, T.Andersson. TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells. Breast Cancer Res 2008; 10:R36; PMID:18435854; http://dx.doi.org/10.1186/bcr2087
40. K.Mahajan, N.P.Mahajan. ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers. Oncogene 2014; 34(32):4162-7
41. G.C.Sellar, K.P.Watt, G.J.Rabiasz, E.A.Stronach, L.Li, E.P.Miller, C.E.Massie, J.Miller, B.Contreras-Moreira, D.Scott, et al. OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer. Nat Genetics 2003; 34:337-43; PMID:12819783; http://dx.doi.org/10.1038/ng1183
42. Y.Cui, Y.Ying, A.van Hasselt, K.M.Ng, J.Yu, Q.Zhang, J.Jin, D.Liu, J.S.Rhim, S.Y.Rha, et al. OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation. PloS One 2008; 3:e2990; PMID:18714356; http://dx.doi.org/10.1371/journal.pone.0002990
43. G.D'Orazi, C.Rinaldo, S.Soddu. Updates on HIPK2: a resourceful oncosuppressor for clearing cancer. J Exp Clin Cancer Res 2012; 31:63; http://dx.doi.org/10.1186/1756-9966-31-63
44. C.G.Lian, Y.Xu, C.Ceol, F.Wu, A.Larson, K.Dresser, W.Xu, L.Tan, Y.Hu, Q.Zhan, et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 2012; 150:1135-46; PMID:22980977; http://dx.doi.org/10.1016/j.cell.2012.07.033